Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems
Sono-Tek reported first-half fiscal 2027 revenue of $10.89 million, up 6% year-over-year, with gross margin expanding to 55% from 51% and operating income up 41% to $1.28 million. Medical market sales surged 289% to $7.05 million, driven by balloon coating and specialty stent-coating systems, but alternative energy sales fell 85% on U.S. clean-energy policy shifts and Q2 net income declined 14% to $366,000. Backlog rose 23% sequentially to $9.51 million, and three post-quarter orders totaling approximately $7.19 million for fiscal 2028 shipment meaningfully increase forward revenue visibility.
Key figures
- Eps
- 0.07
- Revenue
- 10893000
- Guidance
- FY2027 flat to modest revenue growth, reiterated, reflecting timing of several large orders
- Revenue Yoy
- 6%
- Backlog
- 9510000
- Q2 revenue
- 5232000
- Q2 diluted eps
- 0.02
- Q2 revenue yoy
- 1%
- H1 gross margin
- 55%
- Medical sales h1
- 7050000
- Medical sales yoy
- 289%
- Subsequent orders
- 7190000
- Cash and securities
- 17700000
- H1 operating income
- 1279000
- Operating income yoy
- 41%
- Alternative energy yoy
- -85%
- Alternative energy sales h1
- 855000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.